-

Law Offices of Frank R. Cruz Encourages Ardent Health, Inc. (ARDT) Shareholders To Inquire About Securities Fraud Class Action

LOS ANGELES--(BUSINESS WIRE)--The Law Offices of Frank R. Cruz announces that a class action lawsuit has been filed on behalf of shareholders who purchased Ardent Health, Inc. (“Ardent” or the “Company”) (NYSE: ARDT) securities between July 18, 2024 and November 12, 2025, inclusive (the “Class Period”). Ardent investors have until March 9, 2026 to file a lead plaintiff motion.

Law Offices of Frank R. Cruz Encourages Ardent Health, Inc. (ARDT) Shareholders To Inquire About Securities Fraud Class Action

Share

IF YOU SUFFERED A LOSS ON YOUR ARDENT HEALTH, INC. (ARDT) INVESTMENTS, CLICK HERE TO SUBMIT A CLAIM TO POTENTIALLY RECOVER YOUR LOSSES IN THE ONGOING SECURITIES FRAUD LAWSUIT.

You can also contact the Law Offices of Frank R. Cruz to discuss your legal rights by email at info@frankcruzlaw.com, by telephone at (310) 914-5007, or visit our website at www.frankcruzlaw.com.

What Happened?

On November 12, 2025, after market hours, Ardent released its third quarter 2025 financial results, revealing a $43 million decrease in revenue. The Company explained it had “recently completed hindsight evaluations of historical collection trends” and as a result, had significantly negatively revised the collectability of certain accounts receivable.

Additionally, the Company reported a $54 million increase in professional liability reserves due to “recent settlements and ongoing litigations arising from a limited set of claims between 2019 and 2022 in New Mexico” as well as “broader industry trends, including social inflationary pressures.”

On this news, Ardent’s stock price fell $4.75, or 33.8%, to close at $9.30 per share on November 13, 2025, thereby injuring investors.

What Is The Lawsuit About?

The complaint filed in this class action alleges that throughout the Class Period, Defendants made materially false and/or misleading statements, as well as failed to disclose material adverse facts about the Company’s business, operations, and prospects. Specifically, Defendants failed to disclose to investors that: (1) Ardent did not primarily rely on “detailed reviews of historical collections” in determining collectability of accounts receivable nor did “management determine . . . [when an] account is uncollectible.”; (2) the Company’s accounts receivable framework “utilized a 180-day cliff at which time an account became fully reserved,” which allowed Ardent to report higher amounts of accounts receivable during the Class Period, and delay recognizing losses on uncollectable accounts; (3) Ardent did not maintain professional malpractice liability insurance in amounts “sufficient to cover claims arising out of [its] operations”; (4) Ardent’s professional liability reserves were insufficient to cover “significant social inflationary pressure in medical malpractice cases the past several years,” which had been an “increasing dynamic year-over-year” in the Company’s New Mexico market; and (5) as a result, Defendants’ positive statements about the Company’s business, operations, and prospects were materially misleading and/or lacked a reasonable basis at all relevant times.

Contact Us To Participate or Learn More:

If you purchased Ardent securities, wish to learn more about this action, or have any questions concerning this announcement or your rights or interests with respect to these matters, please click HERE or contact us at:
Law Offices of Frank R. Cruz
2121 Avenue of the Stars, Suite 800
Telephone: 310-914-5007
Email: info@frankcruzlaw.com
Visit our website at: www.frankcruzlaw.com

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.

Contacts

Law Offices of Frank R. Cruz
2121 Avenue of the Stars, Suite 800
Telephone: 310-914-5007
Email: info@frankcruzlaw.com
Visit our website at: www.frankcruzlaw.com

The Law Offices of Frank R. Cruz

NYSE:ARDT

Release Summary
Law Offices of Frank R. Cruz Encourages Ardent Health, Inc. (ARDT) Shareholders To Inquire About Securities Fraud Class Action
Release Versions

Contacts

Law Offices of Frank R. Cruz
2121 Avenue of the Stars, Suite 800
Telephone: 310-914-5007
Email: info@frankcruzlaw.com
Visit our website at: www.frankcruzlaw.com

Social Media Profiles
More News From The Law Offices of Frank R. Cruz

Law Offices of Frank R. Cruz Encourages agilon health, inc. (AGL) Shareholders To Inquire About Securities Fraud Class Action

LOS ANGELES--(BUSINESS WIRE)--Law Offices of Frank R. Cruz Encourages agilon health, inc. (AGL) Shareholders To Inquire About Securities Fraud Class Action...

Securities Fraud Investigation Into Navan, Inc. (NAVN) Announced – Investors Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz

LOS ANGELES--(BUSINESS WIRE)--The Law Offices of Frank R. Cruz announces an investigation of Navan, Inc. (“Navan” or the “Company”) (NASDAQ: NAVN) on behalf of investors concerning the Company’s possible violations of federal securities laws. IF YOU ARE AN INVESTOR WHO LOST MONEY ON NAVAN, INC. (NAVN), CLICK HERE TO INQUIRE ABOUT POTENTIALLY PURSUING A CLAIM TO RECOVER YOUR LOSS. What Is The Investigation About? On October 30, 2025, Navan conducted its initial public offering, selling approxima...

Securities Fraud Investigation Into Beta Bionics, Inc. (BBNX) Announced – Investors Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz

LOS ANGELES--(BUSINESS WIRE)--The Law Offices of Frank R. Cruz announces an investigation of Beta Bionics, Inc. (“Beta Bionics” or the “Company”) (NASDAQ: BBNX) on behalf of investors concerning the Company’s possible violations of federal securities laws. IF YOU ARE AN INVESTOR WHO LOST MONEY ON BETA BIONICS, INC. (BBNX), CLICK HERE TO INQUIRE ABOUT POTENTIALLY PURSUING A CLAIM TO RECOVER YOUR LOSS. What Is The Investigation About? On January 8, 2026, Beta Bionics released preliminary fourth q...
Back to Newsroom